The ongoing value of first few X studies for COVID-19 in the Western Pacific Region

Adrian Marcato; James E Fielding; Kristy Crooks; Peter D Massey; Linh-vi Le; Isabel Bergeri; Jodie Mcvernon

Return

The ongoing value of first few X studies for COVID-19 in the Western Pacific Region

Author: Adrian Marcato ¹ ; James E Fielding ² ; Kristy Crooks ^{3
,

4} ; Peter D Massey ^{5
,

6} ; Linh-Vi Le ⁷ ; Isabel Bergeri ⁸ ; Jodie McVernon ^{1
,

9
,

10
,

11}
Author Information

1. The University of Melbourne, Melbourne, Victoria, Australia
2. Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
3. Hunter New England Local Health District, Population Health, Wallsend, New South Wales, Australia
4. Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia
5. College of Medicine and Dentistry, James Cook University, Cairns, Queensland, Australia
6. Hunter New England Local Health District, Population Health, Tamworth, New South Wales, Australia
7. World Health Organization Regional Office for the Western Pacific, Manila, Philippines
8. World Health Organization, Geneva, Switzerland
9. Peter Doherty Institute for Infection and Immunity at the University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia
10. Murdoch Children&rsquo
11. s Research Institute, Melbourne, Victoria, Australia
Publication Type:Journal Article
From: Western Pacific Surveillance and Response 2022;13(1):30-32
CountryWHO-WPRO
Language:English
Abstract: First few ‘X’ (FFX) studies for COVID-19 involve data collection from confirmed cases and their close contacts. They remain relevant especially as many remain susceptible to infection, and as they can provide detailed insight into vaccine effectiveness and the epidemiology of variants of concern, helping to inform a proportionate health response.
Full text:wpsar-13-873.pdf